The SCRIPPS Research Institute, La Jolla, CA, USA.
BIT225 protected against severe disease, indicated by the significant prevention of
body weight loss and absence of death in SARS-CoV-2-infected animals treated
with BIT225 compared to non-treated controls.
BIT225 administered orally significantly reduced virus levels in the lungs of
animals challenged with SARS-CoV-2.
The results show statistically and clinically significant efficacy of BIT225 in this
model of COVID-19.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $3.318M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $500 | 200K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 36018629 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 15608555 | 20 |
View Market Depth
| Last trade - 15.15pm 31/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |